Israel Englander Gelesis Holdings, Inc. Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.11 - $0.52 $32 - $151	291 Added 0.17%	173,910 $28,000
Q4 2022 Feb 14, 2023	SELL	$0.22 - $0.51 $18,557 - $43,019	-84,351 Reduced 32.7%	173,619 $50,000
Q3 2022 Nov 14, 2022	SELL	$0.08 - $1.34 $3,233 - $54,154	-40,414 Reduced 13.54%	257,970 $279,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.